Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||
| Net Income | -14,075 | -7,945 | -4,869 |
| Depreciation Amortization | 1,541 | 252 | 84 |
| Accounts receivable | -2,238 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,685 | 516 | 254 |
| Other Working Capital | -1,901 | -1,180 | 451 |
| Other Operating Activity | 1,437 | 349 | 421 |
| Operating Cash Flow | $-12,551 | $-8,008 | $-3,659 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -35,117 | -8,002 | N/A |
| PPE Investments | -2,132 | -502 | -950 |
| Investing Cash Flow | $-37,249 | $-8,504 | $-950 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 1,448 | 1,002 | N/A |
| Common Stock Issued | 35,324 | 5 | 15 |
| Other Financing Activity | 20,093 | 18,647 | 5,884 |
| Financing Cash Flow | $56,865 | $19,654 | $5,899 |
| Beginning Cash Position | 4,613 | 1,471 | 181 |
| End Cash Position | 11,678 | 4,613 | 1,471 |
| Net Cash Flow | $7,065 | $3,142 | $1,290 |
| Free Cash Flow | |||
| Operating Cash Flow | -12,551 | -8,008 | -3,659 |
| Capital Expenditure | -2,132 | -502 | -950 |
| Free Cash Flow | -14,683 | -8,510 | -4,609 |